Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Systematic Review of Infectious Events in Prospective Trials of Ibrutinib

Benjamin Tillman, MD, James Michael Pauff, MD PhD, Gowri Satyanarayana, MD, Mahsa Sharifi Talbott, PharmD, Jeremy Warner, MD MS

Blood (2017) 130 (Supplement 1): 3460.

https://doi.org/10.1182/blood.V130.Suppl_1.3460.3460

Published: 2017

Journal Articles

Pharmacokinetic Analysis during Antifungal Prophylaxis with Posaconazole Suspension in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Michaela Döring, MD, Karin Melanie Cabanillas Stanchi, Manon Queudeville, MD, Judith Feucht, MD, Patrick Schlegel, MD, Tobias Feuchtinger, MD, Peter Lang, MD, Rupert Handgretinger, Prof. MD, Werner J. Heinz, MD

Blood (2015) 126 (23): 4338.

https://doi.org/10.1182/blood.V126.23.4338.4338

Published: 2015

Journal Articles

Specificity of JAK-Kinase Inhibition Determines Impact on T-Cell Function

Florian Perner, Felix C Saalfeld, cand.MD, Tina M Schnoeder, PhD, Denise Wolleschak, MD, Corinna Fahldieck, Satish Ranjan, Berend H Isermann, MD, Katrin Hebel, PhD, Monika Brunner-Weinzierl, PhD, Thomas Fischer, MD, Florian H Heidel, MD

Blood (2014) 124 (21): 1410.

https://doi.org/10.1182/blood.V124.21.1410.1410

Published: 2014

Journal Articles

Decrease Of T Regulatory Cells In Patients With Myelofibrosis Receiving Ruxolitinib

Giovanni Barosi, MD, Rita Campanelli, Biol. Sci, Gabriela Fois, Biol. Sci, Valentina Poletto, Biol. Sci, Laura Villani, Biol. Sci, Elisa Bonetti, BS, Paolo Catarsi, PhD, Vittorio Rosti, MD, Margherita Massa, PhD

Blood (2013) 122 (21): 4057.

https://doi.org/10.1182/blood.V122.21.4057.4057

Published: 2013

Journal Articles

Hemorrhagic Dysfibrinogenemia Undetectable By Clinical Coagulation Tests and Identified By Isolated Fibrinogen Investigations (Crypto-Dysfibrinogenemia)

Dennis K. Galanakis, MD, Miriam Rafailovich, Ph D, Liudi Zhang, ma

Blood (2013) 122 (21): 3608.

https://doi.org/10.1182/blood.V122.21.3608.3608

Published: 2013

Journal Articles

Cytotoxic CD4 + T cells use granulysin to kill Cryptococcus neoformans , and activation of this pathway is defective in HIV patients

Chun Fu Zheng, Ling Ling Ma, Gareth J. Jones, M. John Gill, Alan M. Krensky, Paul Kubes, Christopher H. Mody

Blood (2006) 109 (5): 2049–2057.

https://doi.org/10.1182/blood-2006-03-009720

Published: 2006

NARROW

Systematic Review of Infectious Events in Prospective Trials of Ibrutinib

Pharmacokinetic Analysis during Antifungal Prophylaxis with Posaconazole Suspension in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Specificity of JAK-Kinase Inhibition Determines Impact on T-Cell Function

Decrease Of T Regulatory Cells In Patients With Myelofibrosis Receiving Ruxolitinib

Hemorrhagic Dysfibrinogenemia Undetectable By Clinical Coagulation Tests and Identified By Isolated Fibrinogen Investigations (Crypto-Dysfibrinogenemia)

Cytotoxic CD4 + T cells use granulysin to kill Cryptococcus neoformans , and activation of this pathway is defective in HIV patients

Email alerts

ASH Publications

American Society of Hematology

Systematic Review of Infectious Events in Prospective Trials of Ibrutinib

Pharmacokinetic Analysis during Antifungal Prophylaxis with Posaconazole Suspension in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Specificity of JAK-Kinase Inhibition Determines Impact on T-Cell Function

Decrease Of T Regulatory Cells In Patients With Myelofibrosis Receiving Ruxolitinib

Hemorrhagic Dysfibrinogenemia Undetectable By Clinical Coagulation Tests and Identified By Isolated Fibrinogen Investigations (Crypto-Dysfibrinogenemia)

Cytotoxic CD4 + T cells use granulysin to kill Cryptococcus neoformans , and activation of this pathway is defective in HIV patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only